Endo International plc Return on Equity

Endo International plc (ENDP) currently reports a ROE of 81.19%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Endo International plc's ROE history and peer comparisons.

Endo International plc's ROE of 81.19% is higher than the Healthcare sector average of -75.84%. That is roughly 207.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Endo International plc's current 81.19% should be judged against Healthcare norms (sector average: -75.84%) and against ENDP's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 81.19%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Endo International plc, and consider following ENDP for alerts when major investors trade the stock.

Endo International plc is classified in the Healthcare sector. On ROE, it currently shows 81.19% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENDP with unrelated industries.